<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57546">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356900</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00060147</org_study_id>
    <nct_id>NCT02356900</nct_id>
  </id_info>
  <brief_title>Hyperbaric VO2max Study</brief_title>
  <official_title>Effects of High Intensity Interval Training in a Hyperoxic-hyperbaric Environment on Exercise Performance at Altitude</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric
      environment for exercise performance at altitude. Subjects will complete a short,
      high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and
      after this training phase, all subjects will be tested for maximum aerobic capacity at a
      simulated high altitude of 15,000ft in a hypobaric chamber, as well as for molecular markers
      of mitochondrial oxidative capacity in a skeletal muscle biopsy.

      A group of individuals of similar characteristics completing this training program in a
      normoxic-normobaric environment will serve as a control.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of funding required to enroll target subject number
  </why_stopped>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum aerobic capacity (VO2max) change</measure>
    <time_frame>Baseline/48 - 72 hrs Post-training</time_frame>
    <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mitochondrial mass change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Immunofluorescence microscopy using citrate synthase staining</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tfam muscle protein content change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Western analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pgc-1a coactivator muscle protein content change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Western analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COX-I gene expression change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Real-time PCR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilatory threshold (VT) change</measure>
    <time_frame>Baseline/48 - 72 hrs Post-training</time_frame>
    <description>Graded exercise test to exhaustion at simulated 15000 ft altitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle phenotype change</measure>
    <time_frame>Baseline/24 hrs Post-training</time_frame>
    <description>Immunofluorescence microscopy using citrate synthase staining</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Exercise Training</condition>
  <arm_group>
    <arm_group_label>Hyperoxic, Hyperbaic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperoxic hyperbaric interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis at 1.4 ATA of oxygen in a hyperbaric chamber.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoxic, Normobaric</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Normoxic, normobaric, interval exercise training Six sessions of 30 min.of High-intensity interval training completed on a 3-times a week basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperoxic hyperbaric interval exercise training</intervention_name>
    <description>Six 30-min high-intensity interval training sessions completed 3-times a week while at 1.4 ATA of oxygen in a hyperbaric chamber.</description>
    <arm_group_label>Hyperoxic, Hyperbaic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normoxic, normobaric, interval exercise training</intervention_name>
    <description>Six 30-min high-intensity interval training sessions completed 3-times a week.</description>
    <arm_group_label>Normoxic, Normobaric</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Used in Hyperoxic hyperbaric interval exercise training intervention</description>
    <arm_group_label>Hyperoxic, Hyperbaic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy, recreationally active or sedentary individuals

        Exclusion Criteria:

          -  VO2max &lt; 35 ml/kg/min - male 30 ml/kg/min - female

          -  chronic cardiovascular or pulmonary diseases

          -  history of pneumothorax

          -  active smoker

          -  pregnant women

          -  non-english speaking

          -  not in full mental capacity

          -  blind

          -  sickle cell trait or disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 10, 2017</lastchanged_date>
  <firstreceived_date>February 2, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>interval training</keyword>
  <keyword>hyperbaric oxygen</keyword>
  <keyword>VO2 max</keyword>
  <keyword>altitude</keyword>
  <keyword>exercise performance</keyword>
  <keyword>mitochondrial oxidative capacity</keyword>
  <keyword>mitochondrial biogenesis</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
